Evidence map›Paper›PMID 34930121›Full record

ArticleBMC gastroenterology2021

Intestinal Behçet's disease complicated by myelodysplastic syndrome and secondary pulmonary alveolar proteinosis: a case report.

Hiroshi Shimizu, Shuzo Sato, Tomohiro Suzuki, Tomomi Sasajima, Yosuke Takahata, Nobuhiko Shinohara, Kosuke Hideshima, Yuko Yokokawa, Nobuo Matsuhashi, Osamu Ichii and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  4. Article
  5. The Expanding Spectrum of Autoinflammatory Diseases.Internal medicine (Tokyo, Japan) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Hiroshi ShimizuDepartment of Gastroenterology, Fukushima Rosai Hospital, Uchigo, Iwaki, Fukushima, 973-8403, Japan.
Shuzo SatoDepartment of Rheumatology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan. shuzo@fmu.ac.jp.ORCID http://orcid.org/0000-0002-8110-8261
Tomohiro SuzukiDepartment of Gastroenterology, Fukushima Rosai Hospital, Uchigo, Iwaki, Fukushima, 973-8403, Japan. t-suzuki@fukushimah.johas.go.jp.
Tomomi SasajimaDepartment of Rheumatology, Fukushima Rosai Hospital, Iwaki, Japan.
Yosuke TakahataDepartment of Gastroenterology, Fukushima Rosai Hospital, Uchigo, Iwaki, Fukushima, 973-8403, Japan.
Nobuhiko ShinoharaDepartment of Gastroenterology, Fukushima Rosai Hospital, Uchigo, Iwaki, Fukushima, 973-8403, Japan.
Kosuke HideshimaDepartment of Gastroenterology, Fukushima Rosai Hospital, Uchigo, Iwaki, Fukushima, 973-8403, Japan.
Yuko YokokawaDepartment of Gastroenterology, Fukushima Rosai Hospital, Uchigo, Iwaki, Fukushima, 973-8403, Japan.
Nobuo MatsuhashiDepartment of Gastroenterology, Fukushima Rosai Hospital, Uchigo, Iwaki, Fukushima, 973-8403, Japan.
Osamu IchiiDepartment of Gastroenterology, Fukushima Rosai Hospital, Uchigo, Iwaki, Fukushima, 973-8403, Japan.
Mayumi TaiDepartment of Gastroenterology, Fukushima Rosai Hospital, Uchigo, Iwaki, Fukushima, 973-8403, Japan.
Yutaka EjiriDepartment of Gastroenterology, Fukushima Rosai Hospital, Uchigo, Iwaki, Fukushima, 973-8403, Japan.
Kiori YanoDepartment of Rheumatology, Fukushima Rosai Hospital, Iwaki, Japan.
Takayuki IkezoeDepartment of Hematology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Hiromasa OhiraDepartment of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Kiyoshi MigitaDepartment of Rheumatology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan.
Fukushima Medical University · JPJapan Organization of Occupational Health and Safety · JPFukushima Medical University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastrointestinal lesions, which sometimes develop in Behçet's disease (BD), are referred to as intestinal BD. Although rare, intestinal BD can be accompanied by myelodysplastic syndrome (MDS) with abnormal karyotype trisomy 8, which is refractory to immunosuppressive therapy. Pulmonary alveolar proteinosis is a rare lung complication of BD and MDS. Herein, we present an extremely rare case of intestinal BD presenting with MDS and several chromosomal abnormalities, followed by secondary pulmonary proteinosis. CASE PRESENTATION: A 58-year-old Japanese woman with a 3-year history of genital ulcers and oral aphthae was admitted to our hospital. The patient developed abdominal pain and persistent diarrhea. Colonoscopy revealed multiple, round, punched-out ulcers from the terminal ileum to the descending colon. Intestinal BD was diagnosed and the patient was treated with colchicine, prednisolone, and adalimumab. However, her symptoms were unstable. Bone marrow examination to investigate the persistent macrocytic anemia revealed the presence of trisomy 8, trisomy 9, and X chromosome abnormalities (48, + 8, + 9, X, i(X) (q10) in 12 out of the examined 20 cells). Based on her hypoplastic bone marrow, the patient was diagnosed with low-risk MDS (refractory anemia). At the age of 61, the patient developed pneumonia with fever and diffuse ground-glass opacities on the lung computed tomography (CT). Chest high-resolution CT and histopathology via transbronchial lung biopsy revealed the presence of pulmonary alveolar proteinosis (PAP). These findings combined with the underlying disease led to the diagnosis of secondary PAP.

conclusionsSecondary pulmonary proteinosis may accompany intestinal BD with MDS and several chromosomal abnormalities. Physicians should pay attention to lung complications, such as PAP, in patients with intestinal BD complicated by MDS. Genetic abnormalities may be associated with the development of such diseases.

Indexed as

Behcet SyndromeIntestinal DiseasesMyelodysplastic SyndromesPulmonary Alveolar ProteinosisFemaleHumansMiddle AgedTrisomyBehçet’s diseaseMyelodysplastic syndromePulmonary alveolar proteinosisTrisomy 8X chromosome anomaly

Identifiers

PMID34930121
PMCPMC8686569
OpenAlexW4200296658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.